We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




新型细菌化验用脂质囊泡替代血液

By LabMedica International staff writers
Posted on 14 Nov 2017
Print article
图片:在琼脂与甲型溶血性肺炎链球菌的混合培养物中,乙型溶血性菌落清晰可辨。(A) L-Hoechst染色的BHI琼脂中纯细菌菌落与混合细菌菌落的荧光图像与明场图像(图片蒙淡马锡生命科学实验室惠赐)。
图片:在琼脂与甲型溶血性肺炎链球菌的混合培养物中,乙型溶血性菌落清晰可辨。(A) L-Hoechst染色的BHI琼脂中纯细菌菌落与混合细菌菌落的荧光图像与明场图像(图片蒙淡马锡生命科学实验室惠赐)。
人们常把疾病归咎于乙型溶血性细菌,如链球菌引起学校儿童中间的流行病,李斯特菌引起许多食源性疾病。现行的检验方法要求把病人样本涂到血液琼脂板上。

确实存在检测特定乙型溶血性菌种的检验方法;然而,这些方法的一般原理是检测基因决定簇和抗原决策簇,而不是乙型溶血性。例子有抗体–抗原试验、基于核酸的测定和最近用经报告因子改造过的噬菌体的方法。

新加坡淡马锡生命科学实验室的科学家及其同事受最初的血液琼脂实验启发,发明了新方法。他们把荧光基团放进脂质体,也就是脂质囊泡,用来控制释药。而脂质体里的荧光分子被压在一起,失去光泽,但当存在乙型溶血性细菌时,脂质体被破开,荧光分子被释放出来并发出荧光。

研究人员把菌株涂到绵羊血液琼脂上,在37 °C下孵育一个通宵,检查溶血行为。新方法名为BETA,它鉴别乙型溶血性细菌与对照细菌的准确率在琼脂板上为100 %,耗费六小时,在肉汤里为99%,需一个小时。科学家说该方法速度快,经济实惠,非常适于发展中国家的诊断。他们还注意到,与乙型溶血性相关的菌落荧光的定性特征与对照细菌产生的本底荧光不同。

该研究的论文发表于2017年9月20日的《ACS》杂志《传感器》分册。作者总结说,以前血液琼脂培养法耗时长,应用范围有限,现在BETA的及时性为扩大应用范围打开了方便之门。速度提高后,基于BETA的喉培养物金标准现在可用作细菌性咽炎的首选诊断检验(而不是一种验证性测定)。BETA的规制可扩展(多孔板),试剂成本低(每次测定2美分),使它适合作为厂内食品安全的一种灵敏的高通量筛选方法,弥补噬菌体检测等特定测定的不足。

Related Links:
淡马锡生命科学实验室

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.